李传波 2023-08-03 15:40:41

SupplyThe company has three production plants, six R&D sites, and three production divisions, namely, Powder Injection Division, Solid Dosage and Hydrographic Injection Division, and Raw Material Division, with a total of 38 modernized production workshops, and an annual production capacity of 3,000 tons of APIs, 1.2 billion powder injections (of which 280 million are lyophilized powder injections), 600 million small-volume injections, 14.5 billion tablets, 10 billion capsules, and 300 million bags of granules, etc. The company has a total production capacity of 1,000 million tons of APIs, 1.2 billion powder injections, 1.2 billion powder injections, and 1.3 billion capsules. 14 dosage forms. The company has more than 400 domestic production approvals and more than 300 foreign registered products. The comprehensive strength of the company ranks 51st in the list of top 100 enterprises in the national pharmaceutical industry and top 20 chemical enterprises, and the export value of chemical preparations has ranked the top in China for many